Slow Heart Study (H-48697 )
Description
Content
The study aims are to document the outcome of patients diagnosed prenatally with immune-mediated second or third degree AVB irrespective of the primary choice of prenatal care. The primary objective will be to determine the rate of transplant-free survival to one year of life of fetuses with AVB based on the prenatal management decision.
Contact
Phone 1: 832–822–2229
IRB: H-48697
Status:
Active
Created:
